Crewe Advisors’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-142
Closed -$2.44K 928
2023
Q1
$2.44K Hold
142
﹤0.01% 705
2022
Q4
$3.15K Hold
142
﹤0.01% 761
2022
Q3
$1K Hold
142
﹤0.01% 1140
2022
Q2
$1K Buy
+142
New +$1K ﹤0.01% 1062